Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
Top Cited Papers
- 28 June 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 42 (1) , 158-164
- https://doi.org/10.1016/s0735-1097(03)00555-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary HypertensionCirculation, 2001
- MEDICAL THERAPY OF PULMONARY HYPERTENSIONClinics in Chest Medicine, 2001
- Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusionHeart, 2001
- Ultrasonicversusjet nebulization of iloprost in severe pulmonary hypertensionEuropean Respiratory Journal, 2001
- Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin AnalogueNew England Journal of Medicine, 2000
- Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot studyEuropean Respiratory Journal, 1999
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Aerosolised prostacyclin in adult respiratory distress syndromeThe Lancet, 1993